The Executive Board of RWE Aktiengesellschaft has resolved today a share buyback program with a volume of up to EUR 1.5 billion. The buyback is to begin this year and be completed within 18 months, ...
Judgment of the Swiss Federal Supreme Court on the VAT liability of sports betting has become legally binding ...
Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that it expects the Swiss SIX exchange to ...
Third-quarter revenue amounted to CHF 585.5 million, a strong increase of 11.2% organic growth, bringing revenue in the first nine months to about CHF 1.9 billion Global launch of intraoral ...
LEG subsidiary and Adler Real Estate GmbH (Adler) enter into share purchase agreement regarding 52.68% of the shares in Brack Capital Properties N.V. (BCP) Adler commits to tender additional 10.1% ...
GENEVA (NOV. 4, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback